Oxaliplatin desensitization for ovarian cancer in pregnancy: A case report

• Kaitlin Nicholson,
• Lily Jia,
• Margaret Rowe,
• Katharine Esselen,
• Naima Joseph,
• Chloe A. Zera,
• Timothy Lax,
• Meghan Shea

Affiliations

Kaitlin Nicholson

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Corresponding author at: 330 Brookline Ave, Boston, MA 02215, United States.

Lily Jia

Harvard Medical School, Boston, MA, United States; Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, United States

Margaret Rowe

Department of Medicine, Penn Medicine, Philadelphia, PA, United States

Katharine Esselen

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States

Naima Joseph

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Boston Medical Center/Boston University, Boston, MA, United States

Chloe A. Zera

Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States

Timothy Lax

Department of Medicine, University of Massachusetts Memorial Health, Worcester, MA, United States

Meghan Shea

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, United States